Form 8-K Sesen Bio, Inc. For: Feb 25
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/27/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Fox Factory sells Marucci Sports for $225M, cuts debt
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
Sesen Bio (SESN) discloses results of internal review
February 25, 2022 8:15 AM ESTSesen Bio (NASDAQ: SESN) disclosed:
As previously announced, the Board of Directors (the Board) of Sesen Bio, Inc. (the Company) initiated an independent internal review conducted by outside counsel with the assistance of subject matter experts (the Review). The Review took place over the course... More
